Our Unique Consortium

Sydney Catalyst is a multi-disciplinary, multi-institutional endeavour established with core funding from the Cancer Institute NSW and based at the University of Sydney.

Read more

Event
EDS: Liver Cancer

Education Dinner Series

EDS: Liver Cancer

Planning has just commenced for another EDS on the topic of liver cancer. Led by Professor Geoff McCaughan and with input from the T2T3 WG incl. Chair Professor Philip Beale, this event is being...

Read more
Event
Scaling New Heights: PhD Opportunities Showcase

Research Showcases

Scaling New Heights: PhD Opportunities Showcase

Are you thinking about undertaking a PhD in cancer research? Are you wondering "what's next?"  Join us for our 'Scaling New Heights: PhD Opportunities Showcase' to hear about some amazing op...

Read more
Event
EDS: Radiotherapy and Chemotherapy - the Oldest Immunotherapies?

Education Dinner Series

EDS: Radiotherapy and Chemotherapy - the Oldest Immunotherapies?

Save the date for our next Education Dinner Series Event on Immunology & Cancer. For the fifth year running, we'll be holding this event in conjunction with DC Down Under and Profess...

Read more
Event
SCITCRS2017

Symposia

SCITCRS2017

The 2017 Sydney Catalyst International Translational Research Symposium is coming soon. Check out our dedicated SCITCRS2017 page for all the information you'll need.   REGISTER HE...

Read more
Research
Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma

T1 | Flagship 2 Pilot and Seed

Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma

Immune checkpoint inhibitor therapy has provided new hope to cancer patients whose tumours have resisted conventional therapy. One of the most recent success stories has been effective treatment o...

Read more
ImmunotherapyNew therapies and diagnosticsLung cancerMesothelioma
News
Sydney Catalyst July 2017 Newsletter

Newsletters

Sydney Catalyst July 2017 Newsletter

This issue is jam-packed with exciting events and congratulations. We love hearing about the successes of our members so we can share the word amongst our tribe.  We hope to hear from yo...

Read more
Research
Ben Kong: Towards a therapeutic vaccination for glioblastoma multiforme

T1 | Flagship 3 Scholarships & Awards

Ben Kong: Towards a therapeutic vaccination for glioblastoma multiforme

The ultimate objective of Ben's research is to create an effective dendritic cell based vaccine for glioblastoma multiforme by exploiting knowledge of DC biology to find the optimum combination of...

Read more
Dendritic cellImmunotherapy
News
Job Opportunity - Sydney Catalyst Project Officer - Education and Communications

News Articles

Job Opportunity - Sydney Catalyst Project Officer - Education and Communications

Sydney Medical School NHMRC Clinical Trials Centre (Sydney Catalyst Central Office) Reference no. 1279/0617 Located at the NHMRC Clinical Trials Centre Part time (2 days a week) fixed term po...

Read more
Research
Sydney Catalyst: Embedding Research in Cancer Healthcare (EnRICH)

T1,T2,T3 | Flagship 1 EnRICH

Sydney Catalyst: Embedding Research in Cancer Healthcare (EnRICH)

The program will develop infrastructure to support translational cancer research, initially with a focus on lung cancer. Specifically, EnRICH will assemble a prospective cohort of 1000 newly diagn...

Read more
Epidemiology and health services researchImplementation researchKnowledge translationLung cancer